| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |